GFB-12811

N/A

Report date: 2026/01/20 18:01:33

NME

Base Information

Drug NameGFB-12811

Drug Alias NameGFB-12811

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclin-dependent kinase 5 inhibitors

TargetsCyclin-dependent kinase 5

Therapy Area/IndicationsPolycystic Kidney Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGoldfinch Bio Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPolycystic Kidney Diseases

Inactive IndicationsN/A

ATC CodeN/A